)
Visual
earnings real time
RenovoRx (RNXT) investor relations material
RenovoRx IAccess Alpha Virtual MicroCap Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.IAccess Alpha Virtual MicroCap Conference summary9 Dec, 2025
Strategic vision and market approach
Focus on localizing cancer therapy to improve patient outcomes and reduce systemic toxicity.
Two-prong strategy: commercializing the FDA-cleared RenovoCath device and developing a drug-device combination platform for pancreatic cancer.
Achieved $900,000 in revenue through Q3 2025 without a dedicated sales force; lean sales infrastructure now in place.
U.S. market prioritized due to favorable regulatory and reimbursement environment; international expansion planned for the future.
Targeting high-volume surgery centers for efficient market penetration with a small sales team.
Clinical and commercial progress
RenovoCath device delivers chemotherapy locally, achieving 100x higher tumor concentration and 50% lower systemic toxicity.
Outpatient procedure with minimal side effects and rapid patient recovery compared to systemic chemotherapy.
Device cleared for broad chemotherapy delivery; initial focus on locally advanced pancreatic cancer, with potential for other hypovascular tumors.
14 centers approved to purchase, 5 active customers, and 24 additional centers requesting quotes.
Phase III TIGeR-PaC trial nearing enrollment completion in 2026, with final data expected in 2027.
Financial outlook and growth drivers
Device-alone U.S. market estimated at $400 million peak annual revenue.
Each patient can generate $40,000–$80,000 in revenue; early sales are lumpy but show repeat usage.
Margins currently at 80%, expected to improve with manufacturing scale and design tweaks.
Over $10 million in cash at Q3 2025; runway extends into mid-2026 with current burn rate.
Revenue growth expected to ramp in late 2026 as more centers onboard and sales cycle matures.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next RenovoRx earnings date
Q4 20251 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
RenovoRx Inc is a U.S.-based medical technology company focused on targeted drug delivery systems. It develops catheter-based platforms for the localized administration of chemotherapy and other therapeutics, primarily for treating cancers. The company aims to improve patient outcomes by reducing systemic exposure and enhancing precision in treatment delivery. It is headquartered in Los Altos, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage